Clinitech Laboratory Makes a Strong Market Debut, Lists at ₹115 with a 20% Premium! Clinitech Laboratory Makes a Strong Market Debut, Lists at ₹115 with a 20% Premium! 

Clinitech Laboratory had a strong market debut, with shares listed at ₹115 on BSE SME, reflecting a 20% premium over the issue price of ₹96. The successful listing highlights the company’s positive market reception.

The IPO consisted of 6.02 lakh newly issued shares, with no offer-for-sale component, and was well-received with an overall subscription of 38.96 times. Retail investors subscribed 49.91 times, and other investors showed strong interest with a subscription of 23.28 times.

Clinitech Laboratory Limited offers diagnostic and healthcare services through 8 centers in Thane and Navi Mumbai. With over 30 years of experience, its promoters ensure high standards. Clinitech performs more than 150 tests across Biochemistry, Immunology, Hematology, Molecular Biology, Serology, Microbiology, and Histopathology.

Clinitech Laboratory’s IPO aims to raise funds for business expansion, upgrade and modernize laboratory equipment, enhance diagnostic services, and meet working capital requirements to support its growth and operational efficiency.